Related Experiment Video

Updated: Aug 14, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Role of transforming growth factor-beta signaling in cancer

M P de Caestecker1, E Piek, A B Roberts

  • 1Laboratory of Cell Regulation and Carcinogenesis, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.

Journal of the National Cancer Institute
|September 7, 2000
PubMed

Insights

Transforming growth factor-beta (TGF-beta) signaling has dual roles in cancer. Tumor cells evade TGF-beta

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor-beta (TGF-beta) signaling is crucial in carcinogenesis, exhibiting both tumor suppressor and oncogenic activities.
  • Tumor cells frequently evade TGF-beta's antiproliferative effects through mutations or altered expression of its signaling pathway components.
  • Dysregulated TGF-beta receptor function and altered ratios of type I and type II receptors in tumors compromise tumor suppression and promote oncogenesis.

Purpose of the Study:

  • To elucidate the complex mechanisms by which tumor cells subvert TGF-beta signaling.
  • To understand the role of Smad proteins and other modulators in TGF-beta pathway dysregulation in cancer.
  • To investigate the interplay between TGF-beta signaling and other pathways like MAPK cascades in carcinogenesis.

Main Methods:

  • Analysis of TGF-beta receptor serine-threonine kinases.
  • Investigation of Smad-mediated intracellular signaling.
  • Exploration of cross-talk between TGF-beta signaling and other cellular pathways, including mitogen-activated protein kinase (MAPK) cascades.

Main Results:

  • Identification of Smad proteins as key intracellular mediators of TGF-beta signaling.
  • Discovery of proteins that modulate Smad signaling, potentially serving as cancer mutation targets.
  • Recognition of the significant contribution of MAPK cascades to TGF-beta signaling.

Conclusions:

  • Tumor cells employ diverse strategies to escape TGF-beta's tumor-suppressive functions.
  • Smad proteins and their modulators are critical in understanding TGF-beta pathway subversion in cancer.
  • Understanding the complex signaling network and cross-talk is essential for deciphering TGF-beta's dual role in cancer.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...